Trevi Therapeutics (TRVI) Enterprise Value (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.75% |
| Dec 31, 2025 | 3.42% |
| Sep 30, 2025 | 4.39% |
| Jun 30, 2025 | -97.45% |
| Mar 31, 2025 | 4.06% |
| Dec 31, 2024 | -64.33% |
| Sep 30, 2024 | 5.76% |
| Jun 30, 2024 | 4.57% |
| Mar 31, 2024 | 12.23% |
| Dec 31, 2023 | 6.64% |
| Sep 30, 2023 | 5.61% |
| Jun 30, 2023 | 15.38% |
| Mar 31, 2023 | 7.68% |
| Dec 31, 2022 | 4.05% |
| Sep 30, 2022 | -61.33% |
| Jun 30, 2022 | -571.80% |
| Mar 31, 2022 | 68.51% |
| Dec 31, 2021 | -25.60% |
| Sep 30, 2021 | 19.51% |
| Jun 30, 2021 | 12.44% |
| Mar 31, 2021 | 7.62% |
| Dec 31, 2020 | 15.56% |
| Sep 30, 2020 | -20.63% |
| Jun 30, 2020 | 16.07% |
| Mar 31, 2020 | 8.15% |
| Dec 31, 2019 | 9.76% |
| Sep 30, 2019 | 11.03% |
| Jun 30, 2019 | -451.42% |
| Mar 31, 2019 | -79.76% |
| Dec 31, 2018 | 46.79% |
| Sep 30, 2018 | -91.75% |
| Jun 30, 2018 | 55.77% |